<DOC>
	<DOCNO>NCT00900549</DOCNO>
	<brief_summary>Heart failure major health problem Canada . Recent advance medical device therapy help reduce morbidity mortality patient problem . Among treatment , cardiac resynchronization therapy ( CRT ) recently show effective improve functional class , quality life exercise tolerance patient severe symptom heart failure prolong duration QRS 12-lead Electrocardiography ( ECG ) .</brief_summary>
	<brief_title>Evaluation Resynchronization Therapy Heart Failure</brief_title>
	<detailed_description>Resynchronization fail ventricle currently achieve pace left right ventricle simultaneously specialize electrode cardiac stimulator . However , controversy persists concern optimal configuration cardiac pacing patient . Right ventricular pace alone show deleterious patient population . The benefit biventricular pace heart failure patient may due primarily leave ventricular stimulation may , patient , decrease presence simultaneous RV stimulation . Preliminary data animal work suggest majority case , LV stimulation alone well RV stimulation , BiV stimulation represent intermediary situation LV RV stimulation .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>The patient eligible undergo ICD implantation replacement They document LVEF ≤ 35 % measure previous 6 month ( without major clinical subsequent event , heart surgery , since LVEF measurement ) If measure echocardiography , LV enddiastolic diameter must ≥ 60 mm The duration QRS &lt; 120 m They sinus rhythm They walk 400 meter screen 6minute walk test ( patient must limit heart failure symptom ) Patients indication permanent ventricular pacing chronotropic insufficiency define follow : Any condition treat physician believe would acceptable patient device NOT program SENSOR ON duration study Second third degree AV block , either persistent intermittent Patients pacemaker ICD pace ventricular chamber 5 % time Patients LV dysfunction associate reversible cause postpartum cardiomyopathy , tachycardia induce cardiomyopathy , acute myocarditis acute toxic cardiomyopathy ( include acute alcoholic ) Patients myocardial infarction within past 6 weeks* define 2 3 follow condition : Prolonged chest pain ECG change suggest AMI Cardiac enzymes elevation twice local upper limit normal ) Patients cardiac surgery within past 6 weeks* Patients moderate severe cardiac valve stenosis ( aortic , mitral , pulmonary tricuspid ) Patients inability limitation walk reason heart failure symptom ( e.g. , angina , intermittent claudication , severe lung condition arthrosis ) Patients severe coexist illness make survival &gt; 6 month unlikely Patients pregnant and/or nursing . Patients inability unwillingness consent comply followup requirement Patients participate another study The 6week period calculate prior begin baseline evaluation implant procedure . This difference come fact protocol include delay 2 8 week implant procedure actual beginning patient 's evaluation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>Cardiac resynchronization therapy</keyword>
	<keyword>ICD</keyword>
</DOC>